Intended Audience: All neonatal nurses

NCC Category Codes: NIC2; NNP3

Objectives: Upon completion, learners will be able to:

Outline the pathogenesis of GBS disease in neonates.
Identify the clinical and laboratory features of GBS disease.
Describe the management of late-onset GBS disease in neonates.
Discuss strategies to prevent late-onset GBS disease.

Learning Outcome:

The learner will increase knowledge of Group B Streptococcus (GBS) infection and its implications for practicing clinicians.

Requirements for Completion: The following requirements are necessary for successful completion of this CNE activity.

Pass the posttest with a score of 80%
Complete and submit the evaluation for this CNE activity

Accreditation
Provider, Academy of Neonatal Nursing, approved by the California Board of Registered Nursing, Provider #CEP 6261; and Florida Board of Nursing, Provider #FBN 3218, content code 2505.

The Academy of Neonatal Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Release Date: February/March 2023
Expiration Date: March 31, 2026

Disclosures:

The authors, nurse planner, planning committee, and the test review panel have no relevant financial relationships with any ineligible companies that may be related to the subjects discussed within this article.
Neither ANN nor the American Nurses Credentialing Center (ANCC) endorses any commercial products discussed/displayed in conjunction with this educational activity.

Disclaimer: The Academy of Neonatal Nursing assumes no responsibility or liability for the content presented. Care of the infant should always be individualized and no one source relied upon for information regarding aspects of care. Accredited status does not imply endorsement by ANN, ANA, or the American Nurses Credentialing Center of any commercial products displayed or discussed in conjunction with an educational activity.

Melissa Bauserman MD, MPH

Appearances